Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanism of Hyperglycemia and Neuroprotection Effect of Pioglitazone in Acute Ischemic Stroke

NCT02195791 is registered in ClinicalTrials.gov with Taipei Medical University Shuang Ho Hospital as lead sponsor.

NCT NCT02195791
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02195791 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanism of Hyperglycemia and Neuroprotection Effect of Pioglitazone in Acute Ischemic Stroke
Lead sponsor
Taipei Medical University Shuang Ho Hospital
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2014
Completion date
August 31, 2016
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke